Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report

Complete response to combination therapy using nivolumab and ipilimumab for metastatic, sarcomatoid collecting duct carcinoma presenting with high expression of programmed death-ligand 1: a case report

Abstract Background Collecting duct carcinoma and sarcomatoid renal cell carcinoma are tumors with poor prognosis. Immune checkpoint inhibitors have been established as the standard treatment for advanced renal cell carcinoma. Some cases of remission of collecting duct carcinoma and sarcomatoid rena...

Full description

Bibliographic Details
Main Authors: Takayoshi Fuu, Kazuyoshi Iijima, Yukiko Kusama, Toshiaki Otsuki, Haruaki Kato
Format: Article
Language:English
Published: BMC 2022-05-01
Series:Journal of Medical Case Reports
Subjects:
Collecting duct carcinoma
Sarcomatoid renal cell carcinoma
Immune checkpoint inhibitors
Programmed death-ligand 1
Immune-related adverse events
Case report
Online Access:https://doi.org/10.1186/s13256-022-03426-3

Similar Items

Similar Items